Jim Cramer on Thermo Fisher: "Maybe This Stock Can Finally Get its Groove Back"

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer put under the spotlight recently. Cramer discussed the company’s latest earnings, as he commented:

“So what do we make of these numbers from Thermo Fisher Scientific, a company I’ve liked for so long? It’s a big life sciences company, reported better than expected quarter this morning… [It] delivered a nice top and bottom line beat with accelerating organic revenue growth. So, maybe this stock can finally get its groove back after mostly trading sideways for the past few years. All for legitimate reasons.”

Thermo Fisher Scientific Inc. (NYSE:TMO) supplies laboratory products, analytical instruments, diagnostics, and biopharma services that support scientific research, healthcare, and industrial applications. On October 1, a caller asked about the stock, and Cramer responded:

“Oh yeah… they really got hurt by COVID. I gotta tell you, as good as Marc Casper is at Thermo Fisher, I’m still saying that Danaher’s better. They’ve both been in the same junk heap, and they shouldn’t have been. Danaher, I think, has got more going for it right now than Thermo Fisher. I would do DHR. That’s a club name.”

While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.